Format
Sort by
Items per page

Send to

Choose Destination

Best matches for SCOPOLAMINE/TU:

Treatment of drooling with scopolamine in pediatric ICU: A case series report. Franco JB et al. Spec Care Dentist. (2018)

[Interest of scopolamine as a treatment of major depressive disorder]. Rigal A et al. Encephale. (2016)

Transdermal scopolamine for the prevention of a salivary fistula after parotidectomy. Mantsopoulos K et al. Br J Oral Maxillofac Surg. (2018)

Search results

Items: 1 to 20 of 1746

1.

The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers.

Tang KS.

Life Sci. 2019 Sep 15;233:116695. doi: 10.1016/j.lfs.2019.116695. Epub 2019 Jul 25. Review.

PMID:
31351082
2.

Identification of a Novel Peptide from β-Casein That Enhances Spatial and Object Recognition Memory in Mice.

Ano Y, Kutsukake T, Sasaki T, Uchida S, Yamada K, Kondo K.

J Agric Food Chem. 2019 Jul 24;67(29):8160-8167. doi: 10.1021/acs.jafc.9b02495. Epub 2019 Jul 10.

PMID:
31241932
3.
4.
5.

Eugenol Attenuates Scopolamine-Induced Hippocampal Cholinergic, Glutamatergic, and Mitochondrial Toxicity in Experimental Rats.

Garabadu D, Sharma M.

Neurotox Res. 2019 May;35(4):848-859. doi: 10.1007/s12640-019-0008-6. Epub 2019 Feb 9.

PMID:
30737653
6.

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.

Zhou J, Wang W, Yang J, Zhu X, Feng L, Xiao L, Wang G.

Trials. 2019 Jan 9;20(1):33. doi: 10.1186/s13063-018-3132-3.

7.

Comparative effects of scopolamine and phencynonate on organophosphorus nerve agent-induced seizure activity, neuropathology and lethality.

Shih TM, Koenig JA, Acon Chen C.

Toxicol Mech Methods. 2019 Jun;29(5):322-333. doi: 10.1080/15376516.2018.1558322. Epub 2019 Jan 22.

PMID:
30558458
8.

Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.

Guo W, Machado-Vieira R, Mathew S, Murrough JW, Charney DS, Grunebaum M, Oquendo MA, Kadriu B, Akula N, Henter I, Yuan P, Merikangas K, Drevets W, Furey M, Mann JJ, McMahon FJ, Zarate CA Jr, Shugart YY.

Transl Psychiatry. 2018 Dec 14;8(1):280. doi: 10.1038/s41398-018-0311-7. Erratum in: Transl Psychiatry. 2019 Mar 5;9(1):108.

9.

BDNF mediates the protective effects of scopolamine in reserpine-induced depression-like behaviors via up-regulation of 5-HTT and TPH1.

Yu H, Lv D, Shen M, Zhang Y, Zhou D, Chen Z, Wang C.

Psychiatry Res. 2019 Jan;271:328-334. doi: 10.1016/j.psychres.2018.12.015. Epub 2018 Dec 3.

PMID:
30529315
10.

Cuscuta chinensis and C. campestris Attenuate Scopolamine-Induced Memory Deficit and Oxidative Damage in Mice.

Lin MK, Lee MS, Huang HC, Cheng TJ, Cheng YD, Wu CR.

Molecules. 2018 Nov 22;23(12). pii: E3060. doi: 10.3390/molecules23123060.

11.

An unusual complication associated with use of transdermal scopolamine.

Rebel A, Gambrel SG, Linville N, Kejner A.

J Clin Anesth. 2019 May;54:81-82. doi: 10.1016/j.jclinane.2018.10.034. Epub 2018 Nov 6. No abstract available.

PMID:
30412814
12.

Development and validation of a sensitive LC-MS/MS method for the estimation of scopolamine in human serum.

Swaminathan SK, Fisher J, Brogden NK, Kandimalla KK.

J Pharm Biomed Anal. 2019 Feb 5;164:41-46. doi: 10.1016/j.jpba.2018.09.051. Epub 2018 Sep 28.

PMID:
30396054
13.

Treatment of drooling with scopolamine in pediatric ICU: A case series report.

Franco JB, Cacita N, Freua KA, Ortega KL, de Melo Peres MPS.

Spec Care Dentist. 2018 Nov;38(6):362-366. doi: 10.1111/scd.12326. Epub 2018 Sep 20.

PMID:
30238487
14.

Scopolamine does not impact declarative and motor memory consolidation across a night of sleep or a day of wakefulness.

Tucker MA, Taylor K, Merchant R, George S, Stoddard C, Kopera K.

Neurobiol Learn Mem. 2018 Nov;155:371-378. doi: 10.1016/j.nlm.2018.08.017. Epub 2018 Aug 30.

PMID:
30172950
15.

Ameliorative effects of Matricaria chamomilla L. hydroalcoholic extract on scopolamine-induced memory impairment in rats: A behavioral and molecular study.

Ionita R, Postu PA, Mihasan M, Gorgan DL, Hancianu M, Cioanca O, Hritcu L.

Phytomedicine. 2018 Aug 1;47:113-120. doi: 10.1016/j.phymed.2018.04.049. Epub 2018 May 7.

PMID:
30166095
16.

The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.

Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A.

Neuropharmacology. 2018 Oct;141:214-222. doi: 10.1016/j.neuropharm.2018.08.022. Epub 2018 Aug 23.

PMID:
30145321
17.

Ethanolic Extract of Opuntia ficus-indica var. saboten Ameliorates Cognitive Dysfunction Induced by Cholinergic Blockade in Mice.

Kwon Y, Liao Y, Koo B, Bae H, Zhang J, Han EH, Yun SM, Lim MK, Lee SH, Jung SY, Ryu JH.

J Med Food. 2018 Oct;21(10):971-978. doi: 10.1089/jmf.2017.4131. Epub 2018 Jul 25.

PMID:
30044674
18.

Schisanhenol improves learning and memory in scopolamine-treated mice by reducing acetylcholinesterase activity and attenuating oxidative damage through SIRT1-PGC-1α-Tau signaling pathway.

Han Y, Yang H, Li L, Du X, Sun C.

Int J Neurosci. 2019 Feb;129(2):110-118. doi: 10.1080/00207454.2018.1503183. Epub 2018 Oct 30.

PMID:
30033800
19.

Hypercholesterolemia impairs contextual fear conditioning memory formation in female mice: evidence for cholinergic dysfunction.

Machado AE, de Sousa G, Mancini G, Faria MS, de Bem AF, Moreira ELG.

Neuroreport. 2018 Sep 5;29(13):1140-1143. doi: 10.1097/WNR.0000000000001091.

PMID:
29994812
20.

Pharmacological manipulation of the olfactory bulb modulates beta oscillations: testing model predictions.

Osinski BL, Kim A, Xiao W, Mehta NM, Kay LM.

J Neurophysiol. 2018 Sep 1;120(3):1090-1106. doi: 10.1152/jn.00090.2018. Epub 2018 May 30.

Supplemental Content

Loading ...
Support Center